The document discusses the funding by The Jeffrey Epstein VI Foundation for new breast cancer research that has led to techniques for early detection of Metastatic Cancer. The research, led by Dr. Jess Ting and his team at Mount Sinai, focuses on analyzing the micro-environment created by tumors to identify specific biomarkers for cancer progression. The study uses wound fluid from post-surgery patients to compare cancerous and non-cancerous environments, aiming to identify patients at high risk of metastasis. The document also highlights the importance of early detection in improving survival rates and mentions the Dubin Breast Center at Mount Sinai.
documents/EFTA00583629.pdf
{}